Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Abdominal Wall
26%
Abdominal Wall Hernia
21%
Artificial Intelligence
35%
Bariatric Surgery
26%
Cancer
29%
Carcinomatous Peritonitis
23%
Chemotherapy
21%
Cholecystectomy
22%
Colon Carcinoma
16%
Connective Tissue Cancer
19%
Cytoreductive Surgery
74%
Desmoplasia
17%
Diseases
31%
Elderly Patient
15%
Endoscopic Surgery
15%
Gastric Bypass
45%
Gastric Bypass Surgery
45%
Gastroesophageal Reflux
16%
Hernia
18%
Hyperthermic Intraperitoneal Chemotherapy
93%
Immune Response
19%
Incision
16%
Indocyanine Green
31%
Intraperitoneal Chemotherapy
39%
Laparoscopic Cholecystectomy
15%
Liposome
16%
Long-Term Outcome
43%
Lymph Node
25%
Lymph Node Metastasis
32%
Melanoma
39%
Metastatic Carcinoma
18%
Morbidity
44%
Neoplasm
36%
Overall Survival
54%
Pancreas Adenocarcinoma
31%
Patient Referral
14%
Peritoneum Mesothelioma
22%
Peritoneum Metastasis
46%
Postoperative Complication
33%
Quality of Life
16%
Recurrent Disease
58%
Reoperation
14%
Retroperitoneal Sarcoma
54%
Roux-en-Y Gastric Bypass
15%
Sentinel Lymph Node Biopsy
18%
Sleeve Gastrectomy
42%
Surgeon
39%
Surgical Anastomosis
54%
Tumor
16%
Ventral Hernia Repair
20%
Keyphrases
Abdominal Wall Reconstruction
22%
Acetylcholinesterase Inhibitors (AChEI)
24%
Anti-inflammatory Activity
19%
Anticholinergic Activity
15%
Artificial Intelligence
18%
Bariatric Surgery
27%
Bifunctional Compounds
23%
Breast Cancer
15%
Cholinergic System
15%
Critical View of Safety
17%
Cytoreduction
18%
Cytoreductive Surgery
63%
Elderly Patients
15%
Experimental Autoimmune Encephalomyelitis
15%
Expression Pattern
16%
Gastroesophageal Reflux Disease
16%
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
100%
Improved Outcomes
15%
Indocyanine Green
15%
Israeli Society
15%
Local Recurrence
18%
Lymph Node Metastasis
26%
Melanocytic Tumor
15%
Melanoma
37%
Melanoma Patients
16%
Metabolic Surgery
26%
Metastasis
20%
Metastatic Lymph Node
15%
Neuroinflammation
23%
Nicotinic Acetylcholine Receptor (nAChR)
20%
One Anastomosis
15%
One-anastomosis Gastric Bypass
44%
Operative
16%
Overall Survival
38%
Pancreatic Ductal Adenocarcinoma
26%
Peritoneal Cancer Index
23%
Peritoneal Mesothelioma
15%
Peritoneal Metastasis
39%
Peritoneal Surface Malignancy
26%
Postoperative Complications
18%
Propensity Score Analysis
15%
Retroperitoneal Sarcoma
46%
Retrospective Analysis
30%
Roux-en-Y Gastric Bypass
15%
Severe Postoperative Complications
16%
Single-center Experience
15%
Sleeve Gastrectomy
46%
Surgeons
19%
Tumor
19%
Ventral Hernia Repair
18%